(Q37949516)

25 August 2017

title

Mechanisms of disease: hypertrophic cardiomyopathy (English)

1 reference

25 August 2017

3

Hugo A Katus

1 reference

25 August 2017

Norbert Frey

1

1 reference

25 August 2017

Mark Luedde

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

25 October 2011

1 reference

Nature Reviews Cardiology

25 August 2017

published in

1 reference

25 August 2017

volume

9

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

91-100

1 reference

https://scigraph.springernature.com/pub.10.1038/nrcardio.2011.159

25 August 2017

exact match

0 references

cites work

Reviews of translational medicine and genomics in cardiovascular disease: new disease taxonomy and therapeutic implications cardiomyopathies: therapeutics based on molecular phenotype

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Phenotypic diversity in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

The molecular genetic basis for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy: from genetics to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

The genetic basis for cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Transgenic rat hearts expressing a human cardiac troponin T deletion reveal diastolic dysfunction and ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

The Prognostic Impact of Septal Myectomy in Obstructive Hypertrophic Cardiomyopathy**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the Am

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Yield of genetic testing in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Pervasive roles of microRNAs in cardiovascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Functional consequences of mutations in the myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Decoding calcium signals involved in cardiac growth and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Novel therapeutic approaches for heart failure by normalizing calcium cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

A Mutant Tropomyosin That Causes Hypertrophic Cardiomyopathy Is Expressed In Vivo and Associated With an Increased Calcium Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Dilated and hypertrophic cardiomyopathy mutations in troponin and alpha-tropomyosin have opposing effects on the calcium affinity of cardiac thin filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Polony multiplex analysis of gene expression (PMAGE) in mouse hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Myocardial collagen turnover in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Biomarkers of myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Assessment of nonischemic myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiac Z-disc signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Multiplex kinase signaling modifies cardiac function at the level of sarcomeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

The sarcomeric Z-disc: a nodal point in signalling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

A myomesin mutation associated with hypertrophic cardiomyopathy deteriorates dimerisation properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Management of symptoms in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cost-effectiveness of implantable cardioverter-defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Ribozyme gene therapy: applications for molecular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Experimental therapies in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Clinical approach to genetic cardiomyopathy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Microvascular Function Is Selectively Impaired in Patients With Hypertrophic Cardiomyopathy and Sarcomere Myofilament Gene Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Severe familial left ventricular non-compaction cardiomyopathy due to a novel troponin T (TNNT2) mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Sex-based comparison of survival in referred patients with hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy-related beta-myosin mutations cause highly variable calcium sensitivity with functional imbalances among individual muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiomyopathies: Myocardial fibrosis assessed by CMR to predict events in HCM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Direct evidence that perhexiline modifies myocardial substrate utilization from fatty acids to lactate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2011.159

Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

31 March 2020

1 reference

12 December 2020

Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy

1 reference

12 December 2020

Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene

1 reference

12 December 2020

Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant alpha-tropomyosins in adult cardiac myocytes

1 reference

12 December 2020

The sarcomere and the nucleus: functional links to hypertrophy, atrophy and sarcopenia

1 reference

12 December 2020

Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction

1 reference

12 December 2020

10.1038/NRCARDIO.2011.159

Identifiers

DOI

1 reference

Dimensions Publication ID

25 August 2017

1006385240

0 references

1 reference